Search Result "atherothrombotic disease"
Platelet Turnover in Atherothrombotic Disease
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 33 Year: 2012 Page: 5328-5343
Author(s): Marie Lordkipanidze
Type 2 Diabetes: An Atherothrombotic Syndrome
Journal: Current Molecular Medicine
Volume: 5 Issue: 3 Year: 2005 Page: 323-332
Author(s): E. J. Dunn, P. J. Grant
Platelet Function Testing in Atherothrombotic Disease
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 33 Year: 2012 Page: 5379-5391
Author(s): Erik Lerkevang Grove,Robert F. Storey,Morten Wurtz
Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 6 Year: 2012 Page: 850-860
Author(s): Burak Pamukcu, Kurt Huber, Gregory Y.H. Lip
Secondary Prevention of Atherothrombotic Cerebrovascular Events
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 365-372
Author(s): Maurizio Paciaroni
The Role of Vascular Endothelial Growth Factor Gene as the Genetic Marker of Atherothrombotic Disorders and in the Gene Therapy of Coronary Artery Disease
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2010 Page: 47-54
Author(s): D. Petrovic
Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 6 Year: 2015 Page: 809-818
Author(s): Ioannis V. Ntalas, Kalliroi I. Kalantzi, Maria E. Tsoumani, John N. Vakalis, Vasileios Vasilakopoulos, Konstantinos Vardakis, Konstantinos N. Vemmos, Maria Voukelatou, Georgios Giannakoulas, Ioannis Giatrakos, Vasileios Giogiakas, Georgios Goumas, Nikos Dimoulis, Antonios Draganigos, Ioannis Efthimiadis, Maria Thoma, Evangelos Kazakos, Nikolaos Kipouridis, Spiros Konstantinou, Haralampos Milionis, Adamantios Bourdakis, Dimitrios Nikolopoulos, Leonidas Peltekis, Nikos Prokopakis, Ioannis Sinteles, Christos S. Stroumbis, Kyriafina Terzoudi, Karmelos Tsilias, Ioannis Xaraktsis, Christos Charmpas, Georgios Hatziathanasiou, Zacharias Christogiannis, Demosthenes B. Panagiotakos, John A. Goudevenos, Alexandros D. Tselepis
Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 6 Year: 2012 Page: 840-849
Author(s): Silvia Montoro-Garcia, Esteban Orenes-Pinero, Francisco Marin, Mariano, Valdes, Gregory YH Lip, Eduard Shantsila
Lessons from the REACH Registry in Europe
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 6 Year: 2012 Page: 725-727
Author(s): Tabita M. Valentijn,Robert J. Stolker
Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 573-586
Author(s): Filippo Luca Fimognari, Simone Scarlata, Raffaele Antonelli-Incalzi